A--Biomedical Computing Support Services
ID: 75N91024R00009Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH NCIBethesda, MD, 20892, USA

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (AN11)

Original Source

https://sam.gov/opp/0271bfc7793544149b530a5c8052fb61/view
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health (NIH) National Cancer Institute (NCI), is seeking qualified contractors to provide Biomedical Data Computing Support Services. The primary objective of this procurement is to manage and analyze large, complex datasets related to cancer research, supporting the Division of Cancer Epidemiology and Genetics (DCEG) in their ongoing studies both domestically and internationally. This initiative is crucial for enhancing the understanding of cancer causes and prevention through effective data management and analysis, which includes establishing communication infrastructure, managing biomedical data, and providing statistical programming and software development. The NCI anticipates awarding multiple Indefinite Delivery Indefinite Quantity (IDIQ) contracts with an ordering period from September 2025 to September 2035. Interested parties should contact Antoinette C. Robinson at antoinette.robinson@nih.gov or +1 240 276 5823 for further information and are encouraged to monitor www.SAM.gov for updates on the solicitation.

    Point(s) of Contact
    CONROY, THOMAS J
    +1 240 276 6725
    thomas.conroy@nih.gov
    Files
    Title
    Posted
    Biomedical_Data_Computing_Support_Services_Presolicitation_2.pdf
    The National Cancer Institute (NCI) is issuing a Pre-Solicitation Notice for Biomedical Data Computing Support Services as part of their ongoing research on cancer causes and prevention. This notice signifies an impending solicitation for acquiring biomedical computing services to support the Division of Cancer Epidemiology and Genetics (DCEG). The objective is to manage and analyze large, complex datasets from various cancer studies, both domestically and internationally. The anticipated contract will encompass three main task areas: 1. Establishing an integrated infrastructure for communication and project coordination. 2. Managing biomedical data, including secure storage and retrieval processes for diverse study types and sizes. 3. Providing statistical programming and analytical software development to enhance NCI research efforts. The NCI plans to award multiple Indefinite Delivery Indefinite Quantity (IDIQ) contracts, effective from September 2025 to September 2035. The primary aim is to identify suppliers, particularly small businesses, that can deliver the required services while integrating with NCI's cloud infrastructure. Interested parties should monitor the Federal Contract Opportunities website for updates on the formal solicitation. This document encapsulates a vital partnership between NCI and potential service providers, emphasizing the importance of data management in impactful cancer research.
    Draft_Biomedical_SOW_1_10_24_1.pdf
    Small_Business_Sources_Sought_Notice_1_10_24_1.pdf
    Lifecycle
    Title
    Type
    A--Biomedical Data Computing Support Services
    Presolicitation
    A--Biomedical Computing Support Services
    Currently viewing
    Sources Sought
    Similar Opportunities
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP) and federal regulations. This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million over the contract period from September 1, 2025, to May 14, 2031. Interested parties must submit their proposals by December 3, 2024, and can direct inquiries to primary contact Samson Shifaraw at samson.shifaraw@nih.gov or secondary contact Valerie Whipple at valerie.whipple@nih.gov.
    Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for scientific management and support services for the National Institute of Mental Health Repository and Genomics Resource (NRGR). The objective of this procurement is to sustain, enhance, and enrich the NRGR, which provides critical biospecimens and genomic data for research on psychiatric disorders, thereby facilitating a deeper understanding of the genetic factors associated with mental health. This initiative is vital for advancing research in the genetics of mental disorders and ensuring broad access to valuable biospecimens and data resources for the scientific community. Proposals are due by November 8, 2024, and must be submitted electronically via the NIH's eCPS system; interested parties should contact Sarah Adan at sarah.adan@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    CRO Support for NCATS Bioanalytical Method Development for Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors to provide support for bioanalytical method development for biologics under a Sources Sought notice. The primary objective is to identify capable organizations that can develop and validate bioanalytical methods for quantitative analyses of novel therapeutic biologics and anti-drug antibodies in various biological matrices, as well as manage project administration and quality assurance. This initiative is crucial for advancing drug development processes and ensuring compliance with regulatory standards, ultimately facilitating the transition of therapeutic candidates to clinical trials. Interested parties must submit their capability statements and relevant information by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov.
    Notice of Intent to Sole-Source
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is planning to non-competitively increase the ceiling on an existing indefinite delivery, indefinite quantity (IDIQ) contract with Planon Corporation for maintenance services related to their proprietary Computer-Aided Facility Management (CAFM) system. This increase is necessary to ensure the continued functionality and optimal performance of the Planon ProCenter system, which is critical to the operations of the National Cancer Institute (NCI). The specialized knowledge required for the maintenance services can only be provided by the incumbent contractor, as integrating a new software solution would incur substantial costs and delays. Interested parties can reach out to Ashley Riggs at ashley.riggs@nih.gov or 240-858-7852 for further information, with the acquisition being processed under FAR Part 12 and a justification and award notice to be posted within 14 days upon award.
    A--NIH NeuroBioBank Brain and Tissue Repository
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the establishment of the NIH NeuroBioBank Brain and Tissue Repository. The objective of this procurement is to create and manage contract collection sites for acquiring, storing, and distributing human brain and central nervous system tissues for research purposes, aimed at advancing the understanding of nervous system disorders. This initiative is critical for enhancing biomedical research by providing well-characterized specimens to researchers, thereby facilitating studies that could lead to improved treatments and interventions. Proposals are due by November 25, 2024, with the anticipated contract performance period starting on May 1, 2025, and extending potentially through multiple option years. Interested vendors should contact Robin D. Knightly at robin.knightly@nih.gov or call +1 301 827 5302 for further information.
    Clinical Site and Study Monitoring for NIMH Funded Research in Global Settings
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for clinical site and study monitoring services for research funded by the National Institute of Mental Health (NIMH) in global settings. The primary objective of this procurement is to support efforts aimed at reducing mental health disparities, particularly in low and middle-income countries, through rigorous monitoring practices that comply with federal regulations and Good Clinical Practice. This five-year contract, expected to commence on November 25, 2024, has an anticipated budget of up to $2,000,000, with firm-fixed price task orders awarded as needed. Interested parties should direct inquiries to Cassandra Conley at cassandra.conley@nih.gov or Rieka Plugge at rieka.plugge@nih.gov.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    NOI Cytiva Sepax C-Pro Cell Processing Systems Software Upgrade
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed price contract for a software upgrade on two Cytiva Sepax C-Pro Cell Processing Systems. The objective of this procurement is to enhance the functionality of these systems, which are critical for the Department of Transfusion Medicine, thereby reducing the need for alternative devices and associated maintenance costs. The software upgrades are necessary to ensure the full operational capabilities of the existing equipment, as Cytiva-Global Life Sciences Solutions USA LLC is the sole supplier of the proprietary software required for this task. Interested parties must submit capability statements by November 14, 2024, at 12:00 PM EST to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    2026 NIAID DMID Omnibus Broad Agency Announcement
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the 2026 NIAID DMID Omnibus Broad Agency Announcement (BAA) aimed at advancing medical countermeasures against infectious diseases. This opportunity encompasses two primary research areas: the development of therapeutics, vaccines, and diagnostics for antimicrobial-resistant pathogens, and the creation of direct acting antivirals targeting viruses with pandemic potential. The initiative is critical for enhancing public health responses to emerging infectious threats and includes funding estimates of up to $8.5 million for Research Area 001 and $20 million for Research Area 002, with proposals due to be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) platform, starting around November 22, 2024. For further inquiries, interested parties may contact Swee L. Teo at teosl@niaid.nih.gov or Brian Madgey at brian.madgey@nih.gov.